Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date:     Monday,...

PITTSBURGH – April 14, 2014 – GE Healthcare and UPMC today announced that the Omnyx™ Manual Read of the Digital HER2 Application has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance will allow...

Philips introduces clinical digital imaging product for pathologists. 510(k) clearance from the US Food and Drug Administration (FDA) allows Philips to market its Her2/neu IHC Digital Manual Read product in the US. Pathologists can now...